Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) Preferred Dividend Payments (2022 - 2026)

Envoy Medical's Preferred Dividend Payments history spans 5 years, with the latest figure at $1.3 million for Q1 2026.

  • On a quarterly basis, Preferred Dividend Payments rose 9.05% to $1.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $5.0 million, a 6.97% decrease, with the full-year FY2025 number at $4.9 million, down 11.14% from a year prior.
  • Preferred Dividend Payments hit $1.3 million in Q1 2026 for Envoy Medical, up from $1.2 million in the prior quarter.
  • Over the last five years, Preferred Dividend Payments for COCH hit a ceiling of $26.4 million in Q4 2023 and a floor of -$1.3 million in Q3 2022.
  • Historically, Preferred Dividend Payments has averaged $3.2 million across 5 years, with a median of $1.4 million in 2024.
  • Biggest five-year swings in Preferred Dividend Payments: surged 216.73% in 2023 and later crashed 94.65% in 2024.
  • Tracing COCH's Preferred Dividend Payments over 5 years: stood at -$1.3 million in 2022, then surged by 2069.83% to $26.4 million in 2023, then crashed by 94.65% to $1.4 million in 2024, then decreased by 18.43% to $1.2 million in 2025, then rose by 17.29% to $1.3 million in 2026.
  • Business Quant data shows Preferred Dividend Payments for COCH at $1.3 million in Q1 2026, $1.2 million in Q4 2025, and $1.3 million in Q3 2025.